Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The results point the way toward a universal coronavirus vaccine that could prevent future pandemics.
People who received a canarypox vector vaccine regimen were no less likely than placebo recipients to acquire HIV.
An extra booster dose raised antibody levels in one third of people with organ transplants, but many remain unprotected.
Tuskegee Institute researchers are finally being recognized for their work in the development of the polio vaccine.
The protein subunit vaccine provides 100% protection against moderate or severe disease, hospitalization and death.
AVAC’s theme for HVAD 2021 is “HIV Vaccine Research: Building on Lessons from COVID.”
The protein vaccine was 96% effective against the original SARS-CoV-2 coronavirus, but less so against new variants.
Could emotional wellbeing and good sleep promote a lasting antibody response to the COVID-19 vaccine?
Messenger RNA vaccines—also called mRNA vaccines—are some of the first COVID-19 vaccines authorized for use in the United States.
Social media posts that make misleading comparisons undermine the science behind the COVID-19 vaccine.
In the United States, an FDA expert advisory panel voted on December 10 to recommend emergency use authorization.
The vaccine from the University of Oxford and AstraZeneca uses a chimpanzee adenovirus vector.
With the first vaccines expected within weeks, a CDC advisory panel votes on how to prioritize access.
Moderna has requested emergency use authorization for its mRNA vaccine candidate.
The vaccine demonstrated 95% efficacy in an ongoing Phase III trial.
Vaccine development is proceeding at an unprecedented pace, but could still hit snags on the way to approval.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.